Fusogenix an Effective Drug Delivery\ Dr. John Lewis's biotechnology company develops next generation nucleic acid medicines and they just announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections. Hear more on what are some of the other advantages of this DNA vaccine even for cancerous cells. Connect with Entos Pharmaceutical: https://www.entospharma.com/ Connect with Dr. John Lewis: https://apcari.ca/meet-the-team/john-d-lewis-research-group/ |
Alberta Impact is proud to partner with Health City in a collaborative effort to shine a light on Alberta lead initiative that are taking the health care industry into the future.
Related Topics on Health
In this panel discussion between BioTalent Canada, University of Waterloo, IMV Inc and Health City; we get to discover how this collaboration has been benefiting University graduates to find successful jobs.
In this special episode, we teamed up with Health City - Edmonton to highlight and celebrate National Nurse Week.
A collaboration that is internationally recognized. iRSM has an interdisciplinary team providing expertise in surgery for neck reconstructive treatments and rehabilitative care.